IMR Press / CEOG / Volume 38 / Issue 1 / pii/1630488484338-389759166

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report
Marked improvement of headaches and vasomotor symptoms with sympathomimetic amines in a woman with sympathetic hyperalgesia-edema syndrome
Show Less
1 The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ (USA)
Clin. Exp. Obstet. Gynecol. 2011, 38(1), 88–89;
Published: 10 March 2011
Abstract

Purpose: To determine if relief from various pain conditions with sympathomimetic amines may be a direct effect on pain fibers or related to improvement of edema. Methods: A woman with severe migraine headaches resistant to standard therapy was treated with dextroamphetamine sulfate. Results: The headaches markedly improved shortly after treatment as did her vasomotor symptoms. However, in this case the inability to lose weight despite dieting related to edema did not improve. Conclusions: The improvement of pain and vasomotor symptoms in this disorder of the sympathetic nervous system does not seem to necessarily be related to edema causing pain. Sympathomimetic amines may have a direct effect on sympathetic nervous system fibers. Thus, a more appropriate term for this condition instead of idiopathic orthostatic cyclic edema would be sympathetic hyperalgesia-edema syndrome.;">
Keywords
Headache
sympathomimetic amines
Edema
Permeability defect
Share
Back to top